Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Larry Maxwell

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Oncotarget|September 15, 2016
Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathwayAmber A Bokhari, Tabari M Baker, Batsukh Dorjbal, et al.
Cancer Research|January 9, 2003
Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancerJohn I Risinger, G Larry Maxwell, G V R Chandramouli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Journal of Proteome Research|August 21, 2012
Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancerNicole P Chappell, Pang-Ning Teng, Brian L Hood, et al.
Journal of Proteome Research|September 22, 2011
Standardization of a sample preparation and analytical workflow for proteomics of archival endometrial cancer tissueAddie Alkhas, Brian L Hood, Kate Oliver, et al.
Gynecologic Oncology|November 13, 2019
Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signaturePaulette Mhawech-Fauceglia, Iyare Izevbaye, Tassja Spindler, et al.
The Pediatric Infectious Disease Journal|June 1, 2023
Outcomes in Pregnant Adolescent Patients Infected With SARS-CoV-2Anh Quynh Nguyen, Ellen Murrin, Sebastian Nasrallah, et al.
Gynecologic Oncology|March 17, 2020
Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequityEli Awad, Rajesh Paladugu, Nathaniel Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarrayMichael A Bidus, John I Risinger, Gadisetti V R Chandramouli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182Neil S Horowitz, Austin Miller, Bunja Rungruang, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Oncotarget|September 15, 2016
Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathwayAmber A Bokhari, Tabari M Baker, Batsukh Dorjbal, et al.
Cancer Research|January 9, 2003
Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancerJohn I Risinger, G Larry Maxwell, G V R Chandramouli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Journal of Proteome Research|August 21, 2012
Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancerNicole P Chappell, Pang-Ning Teng, Brian L Hood, et al.
Journal of Proteome Research|September 22, 2011
Standardization of a sample preparation and analytical workflow for proteomics of archival endometrial cancer tissueAddie Alkhas, Brian L Hood, Kate Oliver, et al.
Gynecologic Oncology|November 13, 2019
Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signaturePaulette Mhawech-Fauceglia, Iyare Izevbaye, Tassja Spindler, et al.
The Pediatric Infectious Disease Journal|June 1, 2023
Outcomes in Pregnant Adolescent Patients Infected With SARS-CoV-2Anh Quynh Nguyen, Ellen Murrin, Sebastian Nasrallah, et al.
Gynecologic Oncology|March 17, 2020
Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequityEli Awad, Rajesh Paladugu, Nathaniel Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarrayMichael A Bidus, John I Risinger, Gadisetti V R Chandramouli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182Neil S Horowitz, Austin Miller, Bunja Rungruang, et al.
Pageof 16